Challenges and Prospects of the Regional Bioequivalence Center Initiative in Ethiopia: a Qualitative Study.
No Thumbnail Available
Date
2020-10
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Abeba University
Abstract
Background: Evaluation of the interchangeability of multi-source generic drug products or bioequivalencestudy has become a crucial activity since the share of generic medicines in healthcare has enormously grown over the past few decades. Among four East African Countries,namely, Ethiopia, Kenya, Uganda and Tanzania, there has been an initiative to establishan accessible and affordable BE center for the regional pharmaceutical manufacturers. Thisstudy aims at assessing the challenges and prospects of the bioequivalence center initiative inEthiopia.
Methods: In-depth interview was conducted with individuals who were Ethiopian affiliates of the Regional Bioequivalence initiative; local pharmaceutica manufacturers, Ethiopian Food andDrug Administration, Regional Bioequivalence Center and other key stakeholders who are involvedin thecenter capacity building. Data were collected using digital voice recorders, andtranscribed. These data were analyzed using an inductive thematic analysis using Nvivo softwareand the findings were presented in narratives using the respondent‟s own words as illustrations.
Results: Based on the findings, four major themes, one as an opportunity and threeaschallenges,wereidentified.ThemerepresenceoftheRegionalBioequivalenceCenterby itself was considered as an opportunity by most of theparticipants .Inaddition,anumber of favorable condition sincluding awareness and demandforproductqualityanddiversity,thepresenceofattractiveincentivepackages for local pharmaceutical manufacturers and the proliferation of the genericmedicines market in the region were mentioned as opportunities. On the other hand, lackof resources and stakeholders‟ commitment as well as lack of regulatory enforcement were identifiedaschallenges.
Conclusions:The Bioequivalence center initiative has not functioned well as initially planned.The findings of this study suggest the need for government and key stakeholders to actively engagein the program to make the initiative viable. The significance of supporting this initiativecould positively contribute to the creation of a competitive local manufacturing sector that willengage in the production of therapeutically interchangeable generic products and ultimatelysafeguard the health of the society at large.
Description
Keywords
Bioavailability, Bioequivalence, Generic drugs, Ethiopia